The scope of CH has a clear focus on the diagnosis and treatment of haematological malignancies. The activities of CH focus specifically on the following haematological disorders and interventions:

• Acute lymphoblastic leukaemia (ALL)
• Acute myeloid leukaemia (AML)
• Chronic myeloid leukaemia (CML)
• Chronic lymphocytic leukaemia (CLL)
• Hodgkin lymphoma (HL)
• Multiple myeloma (MM)
• Non-Hodgkin's lymphoma (NHL)
• Myelodysplastic syndromes (MDS)
• Aplastic anaemia (AA)
• Other haematological diseases
• Stem cell transplantation (SCT)
• Haematopoietic growth factors in oncology
• Supportive care in haematological diseases

After establishment of the Cochrane Childhood Cancer Group in 2006, the issue of paediatric haematological malignancies as part of CH scope is done in close collaboration with this Group.